发明名称 PREVENTIVE AND/OR THERAPEUTIC DRUGS FOR INFLAMMATORY INTESTINAL DISEASES
摘要 <p>The object of the present invention is to provide a medicament useful for preventing and/or treating inflammatory bowel disease. The present invention provides a medicament for preventing and/or treating inflammatory bowel disease which comprises as an active ingredient a pyrazolone derivative represented by the following formula (I) or a physiologically acceptable salt thereof, or a hydrate thereof or a solvate thereof: &lt;CHEM&gt; wherein R&lt;1&gt; represents a hydrogen atom, an aryl group, an alkyl group, or an alkoxycarbonylalkyl group; R&lt;2&gt; represents a hydrogen atom, an aryloxy group, an arylmercapto group, an alkyl group or a hydroxyalkyl group; or R&lt;1&gt; and R&lt;2&gt; are combined with each other to represent an alkylene group; and R&lt;3&gt; represents a hydrogen atom, an alkyl group, a cycloalkyl group, a hydroxyalkyl group, a benzyl group, a naphthyl group, a phenyl group, or a phenyl group substituted with 1 to 3 substituents selected from the group consisting of an alkyl group, an alkoxy group, a hydroxyalkyl group, an alkoxycarbonyl group, an alkylmercapto group, an alkylamino group, a dialkylamino group, a halogen atom, a trifluoromethyl group, a carboxyl group, a cyano group, a hydroxyl group, a nitro group, an amino group and an acetamide group.</p>
申请公布号 EP1553087(A1) 申请公布日期 2005.07.13
申请号 EP20030794292 申请日期 2003.09.09
申请人 MITSUBISHI PHARMA CORPORATION 发明人 ARAKI, YOSHIO;ANDOH, AKIRA;FUJIYAMA, YOSHIHIDE
分类号 A61K31/4152;A61P1/00;A61P43/00;C07D231/20;(IPC1-7):C07D231/20;A61K31/415 主分类号 A61K31/4152
代理机构 代理人
主权项
地址